BNBX Competitors & Alternatives

Compare Applied DNA Sciences, Inc. with similar stocks in the same industry

Asset Management

BNBX

Main Stock
$0.16
-56.75%
Tradestie Score
42
P/E Ratio
0.0
Revenue Growth
34.3%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Molecular Diagnostics
Competitive Moat: None
Core Technology Stack: PCR amplification, LinearDNA enzymatic production, DNA tagging and authentication
Major Customers 5
government health agencies pharmaceutical manufacturers textile/apparel brands supply chain logistics firms clinical laboratories
Critical Suppliers 4
oligonucleotide synthesis providers PCR reagent manufacturers sequencing equipment vendors lab consumables suppliers
Direct Ecosystem Rivals 3

Top Competitors

84 stocks in Asset Management
Company Price Market Cap P/E Score Action
MSIF MSC Income Fund, Inc.
$12.34
-0.80%
$612.93M 6.3 39 Compare
GAIN Gladstone Investment Corporation
$14.58
-2.02%
$532.39M 3.8 44 Compare
PACB Pacific Biosciences of California, Inc.
$1.88
-4.34%
$414.51M - 38 Compare
DXYZ Destiny Tech100 Inc.
$27.41
+3.55%
$305.40M 3.1 62 Compare
NNVC NanoViricides Inc.
$1.24
+0.41%
$25.10M - 37 Compare
GOVX GeoVax Labs, Inc. New
$1.95
+14.37%
$13.67M - 29 Compare
AEMD AETHLON MEDICAL INC
$5.06
-4.44%
$4.85M - 42 Compare
ADTX Aditxt, Inc. Common Stock
$0.01
-77.22%
$3.74M - 55 Compare
CFOR CFOR
- - - - Compare
LMNX LMNX
$9.16
+0.60%
- - 42 Compare

Data updated: Nov 16, 2026 | Industry: Asset Management (SIC None)

84 stocks in this industry